Mankind Pharma Ltd

Registered Office: 208 Okhla Industrial Estate,Phase-III, New Delhi - 110020, New Delhi, India. Phone : 91-11-47476600   Fax: Email : investors@mankindpharma.com Website :www.mankindpharma.com

Initial public offering of 40,058,844 equity shares of face value of Re. 1 each ("Equity Shares") of Mankind Pharma Limited ("The Company" or the "Issuer") for cash at a price of Rs. 1,080 per equity share ("Offer Price") aggregating to Rs. 4326.36 crores, comprising an offer for sale of 3,705,443 equity shares aggregating to Rs. 400.18 crores by Ramesh Juneja, 3,505,149 equity shares aggregating to Rs. 378.56 crores by Rajeev Juneja, 2,804,119 equity shares aggregating to Rs. 302.85 crores by Sheetal Arora (collectively, the "Promoter Selling Shareholders"), 17,405,559 equity shares aggregating to Rs. 1879.80 crores by Cairnhill Cipef Limited, 2,623,863 equity shares aggregating to Rs. 283.38 crores by Cairnhill CGPE Limited, 9,964,711 equity shares aggregating to Rs. 1076.19 crores by Beige Limited and 50,000 equity shares aggregating to Rs. 5.40 crores by Link Investment Trust (collectively, the "Investor Selling Shareholders") (the "Promoter Selling Shareholders" and the "Investor Selling Shareholders", together, the "Selling Shareholders") (the "Offer for Sale" or the "Offer"). The offer shall constitute 10% of the post-offer paid-up equity share capital of the company. Issue Opens On Closes On 25-Apr-23 27-Apr-23 Money Payable On Application Allotment 1080.00 0.00 Minimum Application for shares in Nos : 13 Further Multiples of : 13 RsCr Lead Managers to the Issue Project Cost (Rs.Cr) 0.00 Axis Capital Ltd Project Financed through Current Offer (Rs.Cr) 4326.36   Post Issue Equity Share Capital (Rs.Cr) 40.06 Issue Price (Rs) 1080.00

Projects

Listing of the Equity Shares on the Stock Exchanges

Promoted By

Ramesh Juneja

Rajeev Juneja

Sheetal Arora

Listing At

BSE

NSE

Registrar to the Issue

No Data Available